This article covers 01Health, a UK-based healthtech startup, which has raised £11.2m in a growth funding round led by Gresham House Ventures to roll out its platform for delivering specialist services through local clinics in the UK and the US. It aims to support deployment of clinic-facing software, standardised care pathways and remote specialist oversight to help clinics offer specialist services and reduce patient wait times.
01Health, a UK-based healthtech startup, has raised £11.2m in a growth funding round led by Gresham House Ventures to roll out its platform for delivering specialist services through local clinics across the UK and into the US. The financing underlines investor interest in technologies that let general clinics offer specialist pathways — a potential lever to ease pressure on centralised services and shorten patient wait times.
Specialist outpatient services are often concentrated in large hospital trusts, creating access bottlenecks and long waits. 01Health’s platform aims to decentralise certain treatments by providing the systems and specialist oversight clinics need to deliver services such as orthodontics and sleep medicine. If clinics can safely run specialist pathways without building full in‑house teams and infrastructure, patients could see faster access and the NHS and private providers could increase throughput.
For investors and providers, the approach shifts capital away from bricks-and-mortar facility build-outs and toward software, workflows, and remote clinical supervision. That makes this deal a useful data point for healthtech investors looking at models that scale clinical capacity by extending existing primary and community care settings.
01Health bundles patient acquisition, appointment scheduling, standardised clinical protocols, specialist oversight, treatment workflows, procurement and operational management into a single platform. The firm says it uses AI-powered patient engagement alongside workflow automation and performance tracking to coordinate care across clinic staff and remote specialists.
Practically, the product is designed so a local clinic can launch and manage a specialist service — for example, orthodontics or sleep medicine — by following standardised care pathways and routing complex decisions to remote specialists for review. That reduces the need for clinics to recruit large specialist teams or invest in specialist physical infrastructure.
The £11.2m round was led by Gresham House Ventures, with participation from Balderton Capital, Eka Ventures and Wavemaker360, along with angel investors including Nicolas Cary.
Gresham House Ventures led the deal and provided the bulk of reported funding, signalling conviction in 01Health’s plan to commercialise its clinic-facing platform. Balderton Capital is a Europe-focused early-stage investor with a broad technology portfolio; Eka Ventures and Wavemaker360 bring additional venture backing and regional reach. Angel participation from figures such as Nicolas Cary adds individual‑investor support alongside institutional capital.
01Health says the funds will be used to launch the platform to external clinics, expand across the UK and enter the US market, and extend its technology beyond its initial dental focus into additional specialist healthcare areas.
If you're researching potential backers in this space:
Founded in 2022 by Dr Sonia Szamocki, 01Health was built to let clinics deploy specialist services quickly by combining software, clinical governance and remote specialist input. The company positions its platform as a means for clinic groups and independent practices to add specialist lines of care without building new operational teams or refurbishment projects.
Dr Szamocki’s clinical background informed the product’s emphasis on standardised protocols and specialist oversight, which the firm says are central to ensuring safety and consistency as clinics take on new treatment areas.
The round arrives as investors continue to back digital tools that shift care delivery closer to patients and lower the marginal cost of offering specialist services. In the UK, long waiting lists and capacity constraints create demand for alternative pathways; in the US, a fragmented payer and provider landscape presents opportunities for software that standardises care across disparate clinics.
01Health’s move to expand internationally mirrors a common growth path for UK healthtech companies: validate locally, then target larger or more fragmented markets where platformisation can scale. How quickly clinical governance, reimbursement and regulation adapt to distributed models will determine whether platforms like 01Health become a mainstream route for expanding specialist capacity across Europe and beyond.
| Investors | Investment Focus | Startup Investments | Round Size | Connect |
|---|---|---|---|---|
![]() Eka Ventures( ) | ||||
![]() 2C Ventures( ) | ||||
![]() Specialist VC( ) | ||||
![]() Superangel( ) | ||||
![]() Early Game Ventures( ) | ||||
![]() 4growth VC( ) | ||||
![]() Kogito Ventures( ) | ||||
| All investors | All investor sectors | All funded startups | All funding rounds |
Click here for a full list of 7,589+ startup investors in the UK